Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Childhood encephalitis in the Greater Mekong region (the SouthEast Asia Encephalitis Project): a multicentre prospective study.

Authors:
Jean David Pommier Chris Gorman Yoann Crabol Kevin Bleakley Heng Sothy Ky Santy Huong Thi Thu Tran Lam Van Nguyen Em Bunnakea Chaw Su Hlaing Aye Mya Min Aye Julien Cappelle Magali Herrant Patrice Piola Bruno Rosset Veronique Chevalier Arnaud Tarantola Mey Channa Jerome Honnorat Anne Laure Pinto Sayaphet Rattanavong Manivanh Vongsouvath Mayfong Mayxay Sommanikhone Phangmanixay Khounthavy Phongsavath Ommar Swe Tin Latt Latt Kyaw Htay Htay Tin Kyaw Linn Thi Mai Hung Tran

Lancet Glob Health 2022 07;10(7):e989-e1002

National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.

Background: Encephalitis is a worldwide public health issue, with a substantially high burden among children in southeast Asia. We aimed to determine the causes of encephalitis in children admitted to hospitals across the Greater Mekong region by implementing a comprehensive state-of-the-art diagnostic procedure harmonised across all centres, and identifying clinical characteristics related to patients' conditions.

Methods: In this multicentre, observational, prospective study of childhood encephalitis, four referral hospitals in Cambodia, Vietnam, Laos, and Myanmar recruited children (aged 28 days to 16 years) who presented with altered mental status lasting more than 24 h and two of the following minor criteria: fever (within the 72 h before or after presentation), one or more generalised or partial seizures (excluding febrile seizures), a new-onset focal neurological deficit, cerebrospinal fluid (CSF) white blood cell count of 5 per mL or higher, or brain imaging (CT or MRI) suggestive of lesions of encephalitis. Comprehensive diagnostic procedures were harmonised across all centres, with first-line testing was done on samples taken at inclusion and results delivered within 24 h of inclusion for main treatable causes of disease and second-line testing was done thereafter for mostly non-treatable causes. An independent expert medical panel reviewed the charts and attribution of causes of all the included children. Using multivariate analyses, we assessed risk factors associated with unfavourable outcomes (ie, severe neurological sequelae and death) at discharge using data from baseline and day 2 after inclusion. This study is registered with ClinicalTrials.gov, NCT04089436, and is now complete.

Findings: Between July 28, 2014, and Dec 31, 2017, 664 children with encephalitis were enrolled. Median age was 4·3 years (1·8-8·8), 295 (44%) children were female, and 369 (56%) were male. A confirmed or probable cause of encephalitis was identified in 425 (64%) patients: 216 (33%) of 664 cases were due to Japanese encephalitis virus, 27 (4%) were due to dengue virus, 26 (4%) were due to influenza virus, 24 (4%) were due to herpes simplex virus 1, 18 (3%) were due to Mycobacterium tuberculosis, 17 (3%) were due to Streptococcus pneumoniae, 17 (3%) were due to enterovirus A71, 74 (9%) were due to other pathogens, and six (1%) were due to autoimmune encephalitis. Diagnosis was made within 24 h of admission to hospital for 83 (13%) of 664 children. 119 (18%) children had treatable conditions and 276 (42%) had conditions that could have been preventable by vaccination. At time of discharge, 153 (23%) of 664 children had severe neurological sequelae and 83 (13%) had died. In multivariate analyses, risk factors for unfavourable outcome were diagnosis of M tuberculosis infection upon admission (odds ratio 3·23 [95% CI 1·04-10·03]), coma on day 2 (2·90 [1·78-4·72]), supplementary oxygen requirement (1·89 [1·25-2·86]), and more than 1 week duration between symptom onset and admission to hospital (3·03 [1·68-5·48]). At 1 year after inclusion, of 432 children who were discharged alive from hospital with follow-up data, 24 (5%) had died, 129 (30%) had neurological sequelae, and 279 (65%) had completely recovered.

Interpretation: In southeast Asia, most causes of childhood encephalitis are either preventable or treatable, with Japanese encephalitis virus being the most common cause. We provide crucial information that could guide public health policy to improve diagnostic, vaccination, and early therapeutic guidelines on childhood encephalitis in the Greater Mekong region.

Funding: Institut Pasteur, Institut Pasteur International Network, Fondation Merieux, Aviesan Sud, INSERM, Wellcome Trust, Institut de Recherche pour le Développement (IRD), and Fondation Total.

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2214-109X(22)00174-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210261PMC
July 2022

Publication Analysis

Top Keywords

childhood encephalitis
16
664 children
12
southeast asia
12
neurological sequelae
12
encephalitis
12
greater mekong
12
children
10
mekong region
8
harmonised centres
8
public health
8
encephalitis virus
8
institut pasteur
8
japanese encephalitis
8
encephalitis greater
8
prospective study
8
severe neurological
8
admission hospital
8
risk factors
8
multivariate analyses
8
virus
5

Keyword Occurance

Similar Publications

Chronic T Cell Encephalitis Responsive to Immunotherapy.

Authors:
Arunmozhimaran Elavarasi Garima Shukla Deepti Vibha Vaishali Suri Chandra Sekhar Bal

Ann Indian Acad Neurol 2022 May-Jun;25(3):495-498. Epub 2022 Mar 21.

Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.

Chronic encephalitis manifesting as an epilepsy syndrome most commonly presents as Rasmussen's syndrome, usually characterized by epilepsia partialis continua, hemiparesis, and progressive cortical deficits such as aphasia, hemianopia, and cognitive decline. It is characterized by progressive hemispheric cortical atrophy on imaging and is usually seen in childhood. Adult-onset of the syndrome is rare, and only a few cases have been reported with bilateral symptoms. Read More

View Article and Full-Text PDF
March 2022
Similar Publications

[Differential diagnosis of multiple sclerosis in children].

Authors:
F A Khabirov T I Khaybullin E V Granatov L A Averyanova N N Babicheva A R Khaibullina V A Shikhova M A Yakupov

Zh Nevrol Psikhiatr Im S S Korsakova 2022 ;122(7. Vyp. 2):60-67

Republican Clinical Neurological Center, Kazan, Russia.

At the onset, multiple sclerosis (MS) in children is characterized by a phase of active inflammation with extensive demyelination of the white matter of the CNS, which often mimics this nosology with a whole spectrum of inflammatory demyelinating diseases such as ADEM, anti-MOG encephalitis, ONMSD. In order to formalize the diagnostic process, the International Pediatric Multiple Sclerosis Study Group (IPMSSG) proposed diagnostic criteria for the main immune-mediated demyelinating diseases of the CNS in children, which, in theory, should simplify the diagnostic search. However, in practice, the range of nosologies in the course of differential diagnosis is much wider and often it is not possible to establish an unambiguous diagnosis in the early stages. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Lethal encephalitis in a pediatric patient with SARS-CoV-2.

Authors:
Sevgi Yimenicioğlu Kazım Zararcı Ali Murat Aynacı Ayşe Tekin Yılmaz

Turk J Pediatr 2022 ;64(3):571-575

Departments of Pediatric Infection, Health Ministry Eskisehir City Hospital, Eskişehir, Turkey.

Background: SARS-CoV-2 mostly affects the respiratory system. Some studies have reported neurological disorders associated with SARS-CoV-2. Despite an increase in reported instances, encephalitis caused by COVID-19 infection is still poorly understood. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

A rare case of antileucine-rich glioma-inactivated 1 encephalitis in a 14-year-old girl.

Authors:
Gökçen Özçifçi Tülay Kamaşak Derya Bako Keskin

Turk J Pediatr 2022 ;64(3):566-570

Department of Pediatric Radiology, University of Health Sciences Van Training and Research Hospital, Van, Turkey.

Background: Autoimmune limbic encephalitis in children occurs most frequently in those with antibodies against the N-methyl-D-aspartate glutamatergic receptor. We report the case of a 14-year-old girl who was diagnosed with antileucine-rich glioma-inactivated protein 1 limbic encephalitis.

Case: A fourteen years old, previously healthy girl applied to the emergency department with suspicion of dystonic seizure, ataxia, gait disturbance and speech disorders. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Childhood encephalitis in the Greater Mekong region (the SouthEast Asia Encephalitis Project): a multicentre prospective study.

Authors:
Jean David Pommier Chris Gorman Yoann Crabol Kevin Bleakley Heng Sothy Ky Santy Huong Thi Thu Tran Lam Van Nguyen Em Bunnakea Chaw Su Hlaing Aye Mya Min Aye Julien Cappelle Magali Herrant Patrice Piola Bruno Rosset Veronique Chevalier Arnaud Tarantola Mey Channa Jerome Honnorat Anne Laure Pinto Sayaphet Rattanavong Manivanh Vongsouvath Mayfong Mayxay Sommanikhone Phangmanixay Khounthavy Phongsavath Ommar Swe Tin Latt Latt Kyaw Htay Htay Tin Kyaw Linn Thi Mai Hung Tran

Lancet Glob Health 2022 07;10(7):e989-e1002

National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.

Background: Encephalitis is a worldwide public health issue, with a substantially high burden among children in southeast Asia. We aimed to determine the causes of encephalitis in children admitted to hospitals across the Greater Mekong region by implementing a comprehensive state-of-the-art diagnostic procedure harmonised across all centres, and identifying clinical characteristics related to patients' conditions.

Methods: In this multicentre, observational, prospective study of childhood encephalitis, four referral hospitals in Cambodia, Vietnam, Laos, and Myanmar recruited children (aged 28 days to 16 years) who presented with altered mental status lasting more than 24 h and two of the following minor criteria: fever (within the 72 h before or after presentation), one or more generalised or partial seizures (excluding febrile seizures), a new-onset focal neurological deficit, cerebrospinal fluid (CSF) white blood cell count of 5 per mL or higher, or brain imaging (CT or MRI) suggestive of lesions of encephalitis. Read More

View Article and Full-Text PDF
July 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap